1. Home
  2. BHM vs ATRA Comparison

BHM vs ATRA Comparison

Compare BHM & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluerock Homes Trust Inc.

BHM

Bluerock Homes Trust Inc.

HOLD

Current Price

$11.43

Market Cap

40.6M

Sector

Real Estate

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$5.17

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHM
ATRA
Founded
2022
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
38.9M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
BHM
ATRA
Price
$11.43
$5.17
Analyst Decision
Strong Buy
Sell
Analyst Count
1
2
Target Price
$15.00
$5.00
AVG Volume (30 Days)
11.3K
244.1K
Earning Date
01-01-0001
03-16-2026
Dividend Yield
4.40%
N/A
EPS Growth
N/A
122.52
EPS
N/A
2.57
Revenue
$68,734,000.00
$120,772,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.84
Revenue Growth
36.88
N/A
52 Week Low
$8.05
$3.92
52 Week High
$14.81
$19.15

Technical Indicators

Market Signals
Indicator
BHM
ATRA
Relative Strength Index (RSI) 54.80 48.73
Support Level $10.90 $4.70
Resistance Level $12.11 $5.65
Average True Range (ATR) 0.77 0.48
MACD 0.01 -0.02
Stochastic Oscillator 54.63 31.85

Price Performance

Historical Comparison
BHM
ATRA

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Share on Social Networks: